Cargando…

The Epidemiological, Clinical, and Microbiological Features of Patients with Burkholderia pseudomallei Bacteraemia—Implications for Clinical Management

Patients with melioidosis are commonly bacteraemic. However, the epidemiological characteristics, the microbiological findings, and the clinical associations of Burkholderia pseudomallei bacteraemia are incompletely defined. All cases of culture-confirmed melioidosis at Cairns Hospital in tropical A...

Descripción completa

Detalles Bibliográficos
Autores principales: Prinsloo, Carmen, Smith, Simon, Law, Matthew, Hanson, Josh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10675116/
https://www.ncbi.nlm.nih.gov/pubmed/37999600
http://dx.doi.org/10.3390/tropicalmed8110481
_version_ 1785140988393553920
author Prinsloo, Carmen
Smith, Simon
Law, Matthew
Hanson, Josh
author_facet Prinsloo, Carmen
Smith, Simon
Law, Matthew
Hanson, Josh
author_sort Prinsloo, Carmen
collection PubMed
description Patients with melioidosis are commonly bacteraemic. However, the epidemiological characteristics, the microbiological findings, and the clinical associations of Burkholderia pseudomallei bacteraemia are incompletely defined. All cases of culture-confirmed melioidosis at Cairns Hospital in tropical Australia between January 1998 and June 2023 were reviewed. The presence of bacteraemia was determined and correlated with patient characteristics and outcomes; 332/477 (70%) individuals in the cohort were bacteraemic. In multivariable analysis, immunosuppression (odds ratio (OR) (95% confidence interval (CI)): (2.76 (1.21–6.27), p = 0.02), a wet season presentation (2.27 (1.44–3.59), p < 0.0001) and male sex (1.69 (1.08–2.63), p = 0.02), increased the likelihood of bacteraemia. Patients with a skin or soft tissue infection (0.32 (0.19–0.57), p < 0.0001) or without predisposing factors for melioidosis (0.53 (0.30–0.93), p = 0.03) were less likely to be bacteraemic. Bacteraemia was associated with intensive care unit admission (OR (95%CI): 4.27 (2.35–7.76), p < 0.0001), and death (2.12 (1.04–4.33), p = 0.04). The median (interquartile range) time to blood culture positivity was 31 (26–39) hours. Patients with positive blood cultures within 24 h were more likely to die than patients whose blood culture flagged positive after this time (OR (95%CI): 11.05 (3.96–30.83), p < 0.0001). Bacteraemia portends a worse outcome in patients with melioidosis. Its presence or absence might be used to help predict outcomes in cases of melioidosis and to inform optimal clinical management.
format Online
Article
Text
id pubmed-10675116
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-106751162023-10-24 The Epidemiological, Clinical, and Microbiological Features of Patients with Burkholderia pseudomallei Bacteraemia—Implications for Clinical Management Prinsloo, Carmen Smith, Simon Law, Matthew Hanson, Josh Trop Med Infect Dis Article Patients with melioidosis are commonly bacteraemic. However, the epidemiological characteristics, the microbiological findings, and the clinical associations of Burkholderia pseudomallei bacteraemia are incompletely defined. All cases of culture-confirmed melioidosis at Cairns Hospital in tropical Australia between January 1998 and June 2023 were reviewed. The presence of bacteraemia was determined and correlated with patient characteristics and outcomes; 332/477 (70%) individuals in the cohort were bacteraemic. In multivariable analysis, immunosuppression (odds ratio (OR) (95% confidence interval (CI)): (2.76 (1.21–6.27), p = 0.02), a wet season presentation (2.27 (1.44–3.59), p < 0.0001) and male sex (1.69 (1.08–2.63), p = 0.02), increased the likelihood of bacteraemia. Patients with a skin or soft tissue infection (0.32 (0.19–0.57), p < 0.0001) or without predisposing factors for melioidosis (0.53 (0.30–0.93), p = 0.03) were less likely to be bacteraemic. Bacteraemia was associated with intensive care unit admission (OR (95%CI): 4.27 (2.35–7.76), p < 0.0001), and death (2.12 (1.04–4.33), p = 0.04). The median (interquartile range) time to blood culture positivity was 31 (26–39) hours. Patients with positive blood cultures within 24 h were more likely to die than patients whose blood culture flagged positive after this time (OR (95%CI): 11.05 (3.96–30.83), p < 0.0001). Bacteraemia portends a worse outcome in patients with melioidosis. Its presence or absence might be used to help predict outcomes in cases of melioidosis and to inform optimal clinical management. MDPI 2023-10-24 /pmc/articles/PMC10675116/ /pubmed/37999600 http://dx.doi.org/10.3390/tropicalmed8110481 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Prinsloo, Carmen
Smith, Simon
Law, Matthew
Hanson, Josh
The Epidemiological, Clinical, and Microbiological Features of Patients with Burkholderia pseudomallei Bacteraemia—Implications for Clinical Management
title The Epidemiological, Clinical, and Microbiological Features of Patients with Burkholderia pseudomallei Bacteraemia—Implications for Clinical Management
title_full The Epidemiological, Clinical, and Microbiological Features of Patients with Burkholderia pseudomallei Bacteraemia—Implications for Clinical Management
title_fullStr The Epidemiological, Clinical, and Microbiological Features of Patients with Burkholderia pseudomallei Bacteraemia—Implications for Clinical Management
title_full_unstemmed The Epidemiological, Clinical, and Microbiological Features of Patients with Burkholderia pseudomallei Bacteraemia—Implications for Clinical Management
title_short The Epidemiological, Clinical, and Microbiological Features of Patients with Burkholderia pseudomallei Bacteraemia—Implications for Clinical Management
title_sort epidemiological, clinical, and microbiological features of patients with burkholderia pseudomallei bacteraemia—implications for clinical management
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10675116/
https://www.ncbi.nlm.nih.gov/pubmed/37999600
http://dx.doi.org/10.3390/tropicalmed8110481
work_keys_str_mv AT prinsloocarmen theepidemiologicalclinicalandmicrobiologicalfeaturesofpatientswithburkholderiapseudomalleibacteraemiaimplicationsforclinicalmanagement
AT smithsimon theepidemiologicalclinicalandmicrobiologicalfeaturesofpatientswithburkholderiapseudomalleibacteraemiaimplicationsforclinicalmanagement
AT lawmatthew theepidemiologicalclinicalandmicrobiologicalfeaturesofpatientswithburkholderiapseudomalleibacteraemiaimplicationsforclinicalmanagement
AT hansonjosh theepidemiologicalclinicalandmicrobiologicalfeaturesofpatientswithburkholderiapseudomalleibacteraemiaimplicationsforclinicalmanagement
AT prinsloocarmen epidemiologicalclinicalandmicrobiologicalfeaturesofpatientswithburkholderiapseudomalleibacteraemiaimplicationsforclinicalmanagement
AT smithsimon epidemiologicalclinicalandmicrobiologicalfeaturesofpatientswithburkholderiapseudomalleibacteraemiaimplicationsforclinicalmanagement
AT lawmatthew epidemiologicalclinicalandmicrobiologicalfeaturesofpatientswithburkholderiapseudomalleibacteraemiaimplicationsforclinicalmanagement
AT hansonjosh epidemiologicalclinicalandmicrobiologicalfeaturesofpatientswithburkholderiapseudomalleibacteraemiaimplicationsforclinicalmanagement